SYI_METJA
ID SYI_METJA Reviewed; 1039 AA.
AC Q58357;
DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1996, sequence version 1.
DT 03-AUG-2022, entry version 130.
DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003};
DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003};
DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003};
DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003};
GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; OrderedLocusNames=MJ0947;
OS Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM
OS 10045 / NBRC 100440) (Methanococcus jannaschii).
OC Archaea; Euryarchaeota; Methanomada group; Methanococci; Methanococcales;
OC Methanocaldococcaceae; Methanocaldococcus.
OX NCBI_TaxID=243232;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440;
RX PubMed=8688087; DOI=10.1126/science.273.5278.1058;
RA Bult C.J., White O., Olsen G.J., Zhou L., Fleischmann R.D., Sutton G.G.,
RA Blake J.A., FitzGerald L.M., Clayton R.A., Gocayne J.D., Kerlavage A.R.,
RA Dougherty B.A., Tomb J.-F., Adams M.D., Reich C.I., Overbeek R.,
RA Kirkness E.F., Weinstock K.G., Merrick J.M., Glodek A., Scott J.L.,
RA Geoghagen N.S.M., Weidman J.F., Fuhrmann J.L., Nguyen D., Utterback T.R.,
RA Kelley J.M., Peterson J.D., Sadow P.W., Hanna M.C., Cotton M.D.,
RA Roberts K.M., Hurst M.A., Kaine B.P., Borodovsky M., Klenk H.-P.,
RA Fraser C.M., Smith H.O., Woese C.R., Venter J.C.;
RT "Complete genome sequence of the methanogenic archaeon, Methanococcus
RT jannaschii.";
RL Science 273:1058-1073(1996).
CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS
CC can inadvertently accommodate and process structurally similar amino
CC acids such as valine, to avoid such errors it has two additional
CC distinct tRNA(Ile)-dependent editing activities. One activity is
CC designated as 'pretransfer' editing and involves the hydrolysis of
CC activated Val-AMP. The other activity is designated 'posttransfer'
CC editing and involves deacylation of mischarged Val-tRNA(Ile).
CC {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L-
CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666,
CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528,
CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_02003};
CC -!- COFACTOR:
CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_02003};
CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and
CC one for editing. The misactivated valine is translocated from the
CC active site to the editing site, which sterically excludes the
CC correctly activated isoleucine. The single editing site contains two
CC valyl binding pockets, one specific for each substrate (Val-AMP or Val-
CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; L77117; AAB98949.1; -; Genomic_DNA.
DR PIR; C64418; C64418.
DR RefSeq; WP_010870461.1; NC_000909.1.
DR AlphaFoldDB; Q58357; -.
DR SMR; Q58357; -.
DR STRING; 243232.MJ_0947; -.
DR PRIDE; Q58357; -.
DR EnsemblBacteria; AAB98949; AAB98949; MJ_0947.
DR GeneID; 1451844; -.
DR KEGG; mja:MJ_0947; -.
DR eggNOG; arCOG00807; Archaea.
DR HOGENOM; CLU_001493_1_1_2; -.
DR InParanoid; Q58357; -.
DR OMA; HLGTAWN; -.
DR OrthoDB; 4914at2157; -.
DR PhylomeDB; Q58357; -.
DR Proteomes; UP000000805; Chromosome.
DR GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IBA:GO_Central.
DR GO; GO:0000049; F:tRNA binding; IEA:InterPro.
DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule.
DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IBA:GO_Central.
DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1.
DR Gene3D; 3.40.50.620; -; 2.
DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1.
DR InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR InterPro; IPR002300; aa-tRNA-synth_Ia.
DR InterPro; IPR033709; Anticodon_Ile_ABEc.
DR InterPro; IPR002301; Ile-tRNA-ligase.
DR InterPro; IPR023586; Ile-tRNA-ligase_type2.
DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR PANTHER; PTHR42780; PTHR42780; 1.
DR Pfam; PF08264; Anticodon_1; 1.
DR Pfam; PF00133; tRNA-synt_1; 1.
DR PRINTS; PR00984; TRNASYNTHILE.
DR SUPFAM; SSF47323; SSF47323; 1.
DR SUPFAM; SSF50677; SSF50677; 1.
DR TIGRFAMs; TIGR00392; ileS; 1.
DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE 3: Inferred from homology;
KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding;
KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc.
FT CHAIN 1..1039
FT /note="Isoleucine--tRNA ligase"
FT /id="PRO_0000098580"
FT MOTIF 46..56
FT /note="'HIGH' region"
FT MOTIF 600..604
FT /note="'KMSKS' region"
FT BINDING 603
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003"
SQ SEQUENCE 1039 AA; 122234 MW; 7163C46B4AE08AC0 CRC64;
MKKVEPVNFR ELDKKIKKFW EENDIYQKVK KKNERNKEFY FVDGPPYCSG AIHLGTAWNK
IIKDTYLRFK RMQGYNVLDK AGWDMHGLPI EVKVENEFGI KNKKEIETKI GVKQFIEKCK
EFALKHKEIM EKQFKNLGVW LDWENAYMPI TKEYMEIGWW TLKVAHEKGL LTRDLRVVYW
CPRCETALAE HEVRGEYKEV YDPSVYVKFR LANEENTYIV IWTTTPWTLV ANLAVTVHPD
YDYAYVEVEF DDKKEVWIIA EKLVEEVINK AKKFHNIKNY KIIKKVKGKE LEGIKYIHPL
LEENERQKEF AELENAHTVI LGEHVTLEGG TGLVHTAPGH GEEDFEVGKK YNLPIYSPID
DEGKYVEGKW KGVFVKDADA EIIETLKNKG LLVYAGKIKH SYPHCWRCKT PLLFRATEQW
FLEISKIKDN IIEHAKTVQW IPHWVETRYI NGVKFVGDWN ISRQRYWGIP IPVWVCEKCG
KYIVVGSVEE LEEKMINKDE VGEINDLHKP TVDKIKLRCE CGGEMKRVPD VLDVWFDSGL
APYASIGVKE LKKADFITEG HDQVTKWFYS QHALSAIVFN DIPYKKCLMH GFTLDEHGDK
MSKSLGNVVN PDDVVEKYGA DLLRFYLLSA NKVWEDLRFV WSEMDDVLSL FNTLWNAYMF
AVNYMVLDNF KPDEKYFEYL KDEDRWIVSR INSVAKIAIE NLEVPYFHTY TWTLKDFILN
DLSRWYIRLI RDRTWKEKDD ADKLAAYQTL YYVLLKLATI LAPVAPHTAE AIYQNLKTED
MEESIFMNKI EVDEEFIDEE LERDMAIVRD VVDAIYRGRD RIKYTLRYPL KEITIAGGEE
VKKAVERFEY IIKEQGNVKN IKFGEVEGSK YIIKPNYREL GKRYRSEVPK VVEALNKADA
KELMERLKEG AVILDGYEIK PEYVEIRLEI PEHIAGVEFS KGTVFINTEI TDDLIKEGLM
REVIRRIQAM RKDMDLDIEE KIKIKVEGID LDEFKEIIER EVRGQFVDEI KADYEKDWEI
KTPNGEKYNV KIAIERINK